Maya Mehrara is a News Reporter at Newsweek based in London, U.K.. Her focus is reporting on international news. She has covered Ukraine, Russia, immigration issues, and the revolution in Iran.

Scotiabank raised the firm’s price target on Vertex Pharmaceuticals (VRTX) to $450 from $433 and keeps a Sector Perform rating on the shares. The company had a strong Q4, with revenue beating ...

Vertex insists it isn't buying an alternative to VX-880 however, rather that ViaCyte's "tools, technologies and assets" will help manufacture its lead candidate and take it through development.

Vertex Pharma could be close to succeeding in the long-standing quest to find an alternative to potentially addictive opioids for the treatment of pain associated with common medical procedures.

Start by entering details like pill imprint code, color, and shape. Our website services, content, and products are for informational purposes only. Healthline does not provide medical advice ...

Readers help support Windows Report. We may get a commission if you buy through our links. Snipping Tool is an excellent in-built tool that lets you take screenshots on your Windows 11, but many who ...